NON-SMALL CELL LUNG CANCER (NSCLC)
Clinical trials for NON-SMALL CELL LUNG CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to keep lung cancer from returning after surgery
Disease control CompletedThis study tested whether adding tiragolumab to atezolizumab (both immunotherapy drugs) helps prevent lung cancer from coming back after surgery and chemotherapy. It involved 56 adults with a specific type of non-small cell lung cancer that had been completely removed. The main g…
Matched conditions: NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Tweaking scan settings may sharpen lung cancer staging
Knowledge-focused CompletedThis study looked at how changing the way PET/CT images are taken and processed affects how accurately doctors can tell if lung cancer has spread to lymph nodes in the chest. Thirty adults with non-small cell lung cancer who were already scheduled for a standard PET/CT scan took …
Matched conditions: NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Apr 29, 2026 01:50 UTC